ArticleCurrent microbiology2025
Comprehensive Genomic Profiling and In Vitro Probiotic and Safety Assessments of Enterococcus faecium UFAS147 Isolated from Moroccan Goat Feces.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enterococci are beneficial commensal bacteria recognized for their probiotic effects and are commonly utilized as adjunct cultures in dairy product fermentation. However, their ability to acquire antibiotic resistance and contribute to infections raises significant safety concerns. In this study, both in vitro assays and genome sequencing were conducted to evaluate the safety, functionality, and probiotic potential of Enterococcus faecium UFAS147, isolated from Moroccan goat feces. The strain tolerated acidic conditions (96.79% survival at pH 1.5) and bile salt (1-4%), with notable autoaggregation (33.66%), coaggregation with Salmonella typhymurium ATCC14028 (72.78%), and Staphylococcus aureus B1 (65.55%). Safety assays confirmed the absence of hemolytic activity, mucin degradation, and biogenic amine production. Antibiotic susceptibility testing showed sensitivity to six antibiotics. PCR analysis further confirmed the absence of vanA and vanB genes associated with vancomycin resistance. Genome analysis revealed a length of 2,606,111 bp with a GC content of 38.11% and the absence of genes linked to acquired antimicrobial resistance, cytolysins, and biogenic amine production. Genes supporting probiotic traits, such as Enterocin A, Enterocin P, and Enterolysin A, acid and bile resistance, adhesion, and colonization were identified. These findings highlight E. faecium UFAS147 as a promising candidate for probiotic applications.
Indexed as
Identifiers
40608139What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.